Da Huo, Tong Yu, Ying Shen, Yang Pan, Fu Li, Shujuan Cui, Bing Lyu, Zhichao Liang, Daitao Zhang, Peng Yang, Quanyi Wang, Yue Sun, Zhaomin Feng
{"title":"SARS-CoV-2组粒亚变体BF.7.14和BA.5.2.48感染的临床特征比较——中国，2022年10 - 12月","authors":"Da Huo, Tong Yu, Ying Shen, Yang Pan, Fu Li, Shujuan Cui, Bing Lyu, Zhichao Liang, Daitao Zhang, Peng Yang, Quanyi Wang, Yue Sun, Zhaomin Feng","doi":"10.46234/ccdcw2023.096","DOIUrl":null,"url":null,"abstract":"<p><strong>What is already known about this topic?: </strong>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, the clinical manifestations resulting from different SARS-CoV-2 variants may demonstrate significant variation.</p><p><strong>What is added by this report?: </strong>We conducted a comparative analysis of the clinical features associated with SARS-CoV-2 Omicron subvariants BF.7.14 and BA.5.2.48 infections. The results of our study indicate that there are no substantial differences in clinical manifestations, duration of illness, healthcare-seeking behaviors, or treatment between these two subvariants.</p><p><strong>What are the implications for public health practice?: </strong>Timely identification of alterations in the clinical spectrum is crucial for researchers and healthcare practitioners in order to enhance their comprehension of clinical manifestations, as well as the progression of SARS-CoV-2. Furthermore, this information is beneficial for policymakers in the process of revising and implementing appropriate countermeasures.</p>","PeriodicalId":9867,"journal":{"name":"China CDC Weekly","volume":"5 23","pages":"511-515"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/44/fa/ccdcw-5-23-511.PMC10316608.pdf","citationCount":"3","resultStr":"{\"title\":\"A Comparison of Clinical Characteristics of Infections with SARS-CoV-2 Omicron Subvariants BF.7.14 and BA.5.2.48 - China, October-December 2022.\",\"authors\":\"Da Huo, Tong Yu, Ying Shen, Yang Pan, Fu Li, Shujuan Cui, Bing Lyu, Zhichao Liang, Daitao Zhang, Peng Yang, Quanyi Wang, Yue Sun, Zhaomin Feng\",\"doi\":\"10.46234/ccdcw2023.096\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>What is already known about this topic?: </strong>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, the clinical manifestations resulting from different SARS-CoV-2 variants may demonstrate significant variation.</p><p><strong>What is added by this report?: </strong>We conducted a comparative analysis of the clinical features associated with SARS-CoV-2 Omicron subvariants BF.7.14 and BA.5.2.48 infections. The results of our study indicate that there are no substantial differences in clinical manifestations, duration of illness, healthcare-seeking behaviors, or treatment between these two subvariants.</p><p><strong>What are the implications for public health practice?: </strong>Timely identification of alterations in the clinical spectrum is crucial for researchers and healthcare practitioners in order to enhance their comprehension of clinical manifestations, as well as the progression of SARS-CoV-2. Furthermore, this information is beneficial for policymakers in the process of revising and implementing appropriate countermeasures.</p>\",\"PeriodicalId\":9867,\"journal\":{\"name\":\"China CDC Weekly\",\"volume\":\"5 23\",\"pages\":\"511-515\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/44/fa/ccdcw-5-23-511.PMC10316608.pdf\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"China CDC Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46234/ccdcw2023.096\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"China CDC Weekly","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46234/ccdcw2023.096","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Comparison of Clinical Characteristics of Infections with SARS-CoV-2 Omicron Subvariants BF.7.14 and BA.5.2.48 - China, October-December 2022.
What is already known about this topic?: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, the clinical manifestations resulting from different SARS-CoV-2 variants may demonstrate significant variation.
What is added by this report?: We conducted a comparative analysis of the clinical features associated with SARS-CoV-2 Omicron subvariants BF.7.14 and BA.5.2.48 infections. The results of our study indicate that there are no substantial differences in clinical manifestations, duration of illness, healthcare-seeking behaviors, or treatment between these two subvariants.
What are the implications for public health practice?: Timely identification of alterations in the clinical spectrum is crucial for researchers and healthcare practitioners in order to enhance their comprehension of clinical manifestations, as well as the progression of SARS-CoV-2. Furthermore, this information is beneficial for policymakers in the process of revising and implementing appropriate countermeasures.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
